Pediatric Cancer Survivors at Increased Risk for Endocrine AbnormalitiesJuly 5, 2016EndocrinologyOncologyPediatrics
FDA Panel Narrowly Endorses Empagliflozin’s Cardiovascular Mortality BenefitJune 29, 2016CardiologyDiabetesEndocrinology
Menopause and Cardiovascular Risk Examined in Type 1 DiabetesJune 28, 2016CardiologyDiabetesEndocrinologyWomen's Health
How young is too young? The optimal age for transitioning for transgender and gender nonconforming youthJune 23, 2016Mental HealthPediatricsEndocrinology
Benefits of Lifestyle Intervention Only Brief in Some T2DM PatientsJune 23, 2016DiabetesEndocrinologyObesity
Long-term Metformin Use Protective Against Neurodegenerative DiseaseJune 23, 2016DiabetesEndocrinologyNeurology
Starting With Combination Diabetes Therapy Beats Initial MonotherapyJune 2, 2016DiabetesEndocrinology
Initial Monotherapy Safe in Type 2 Diabetes but Must Be Abandoned Quickly if IneffectiveMay 27, 2016DiabetesEndocrinology
